Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomasfor Metastatic Dedifferentiated LiposarcomaSites in Albuquerque +240 more locationsSponsor: National Cancer Institute (NCI)Sex: All·Age: 18+Code: NCT06422806·Phase 3·Recruiting·Listed May 2024Apply to this trial
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trialfor Metastatic Colorectal AdenocarcinomaSites in Albuquerque +164 more locationsSponsor: Alliance for Clinical Trials in OncologySex: All·Age: 18+Code: NCT05673148·Phase 2·Recruiting·Listed Jan 2023Apply to this trial
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancerfor Hematopoietic and Lymphatic System NeoplasmSites in Albuquerque +190 more locationsSponsor: Children's Oncology GroupSex: Female·Age: Up to 39Code: NCT06513962·Phase 3·Recruiting·Listed Jul 2024Apply to this trial
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgeryfor Grade 2 MeningiomaSites in Albuquerque +111 more locationsSponsor: NRG OncologySex: All·Age: 18+Code: NCT03180268·Phase 3·Recruiting·Listed Jun 2017Apply to this trial
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)for Cervical CarcinomaSites in Albuquerque +17 more locationsSponsor: National Cancer Institute (NCI)Sex: Female·Age: 25+·Accepts healthy volunteersCode: NCT07281430·Recruiting·Listed Dec 2025Apply to this trial
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancerfor Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Sites in Albuquerque +145 more locationsSponsor: NRG OncologySex: All·Age: 18+Code: NCT06532279·Phase 2·Recruiting·Listed Aug 2024Apply to this trial
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinomafor Endometrial AdenocarcinomaDrug: IpilimumabSites in Albuquerque +121 more locationsSponsor: National Cancer Institute (NCI)Sex: Female·Age: 18+Code: NCT05112601·Phase 2·Recruiting·Listed Nov 2021Apply to this trial
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancersfor Metastatic Salivary Gland CarcinomaSites in Albuquerque +141 more locationsSponsor: NRG OncologySex: All·Age: 18+Code: NCT05408845·Phase 2·Recruiting·Listed Jun 2022Apply to this trial
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)for B Acute Lymphoblastic LeukemiaSites in Albuquerque +141 more locationsSponsor: National Cancer Institute (NCI)Sex: All·Age: 366 Days - 46Code: NCT06124157·Phase 2·Recruiting·Listed Nov 2023Apply to this trial
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLyfor B Acute Lymphoblastic LeukemiaSites in Albuquerque +186 more locationsSponsor: Children's Oncology GroupSex: All·Age: 365 Days - 25Code: NCT03959085·Phase 3·Recruiting·Listed May 2019Apply to this trial
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatmentfor Hematopoietic and Lymphatic System NeoplasmSites in Albuquerque +27 more locationsSponsor: NRG OncologySex: All·Age: 18+·Accepts healthy volunteersCode: NCT06279013·Recruiting·Listed Feb 2024Apply to this trial
Project: Every Child for Younger Patients With Cancerfor Adrenal Gland PheochromocytomaSites in Albuquerque +226 more locationsSponsor: Children's Oncology GroupSex: All·Age: Up to 25Code: NCT02402244·Recruiting·Listed Mar 2015Apply to this trial
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWTfor Anaplastic Kidney Wilms TumorSites in Albuquerque +171 more locationsSponsor: Children's Oncology GroupSex: All·Age: Up to 30Code: NCT04322318·Phase 2·Recruiting·Listed Mar 2020Apply to this trial
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trialfor Metastatic Digestive System Neuroendocrine Tumor G1Sites in Albuquerque +30 more locationsSponsor: National Cancer Institute (NCI)Sex: All·Age: 18+Code: NCT05773274·Phase 2·Recruiting·Listed Mar 2023Apply to this trial
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Studyfor Acute Lymphoblastic LeukemiaSites in Albuquerque +155 more locationsSponsor: PedAL BCU, LLCSex: All·Age: Up to 22Code: NCT04726241·Phase 1, Phase 2·Recruiting·Listed Jan 2021Apply to this trial
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)for GanglioneuroblastomaSites in Albuquerque +142 more locationsSponsor: Children's Oncology GroupSex: All·Age: 365 Days - 30Code: NCT03126916·Phase 3·Recruiting·Listed Apr 2017Apply to this trial
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatmentfor Plasma Cell MyelomaSites in Albuquerque, Rio Rancho +387 more locationsSponsor: SWOG Cancer Research NetworkSex: All·Age: All agesCode: NCT05561387·Phase 3·Recruiting·Listed Sep 2022Apply to this trial
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancerfor Previously Treated Non-Small Cell Lung CancerSites in Albuquerque, Rio Rancho +948 more locationsSponsor: SWOG Cancer Research NetworkSex: All·Age: 18+Code: NCT03851445·Phase 2, Phase 3·Recruiting·Listed Feb 2019Apply to this trial
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)for Recurrent Lung Non-Small Cell CarcinomaSites in Albuquerque +371 more locationsSponsor: SWOG Cancer Research NetworkSex: All·Age: 18+Code: NCT05642572·Phase 2·Recruiting·Listed Dec 2022Apply to this trial
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavityfor Gastric AdenocarcinomaSites in Albuquerque +77 more locationsSponsor: ECOG-ACRIN Cancer Research GroupSex: All·Age: 18+Code: NCT07001748·Phase 2, Phase 3·Recruiting·Listed Jun 2025Apply to this trial
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcomafor Embryonal RhabdomyosarcomaSites in Albuquerque +163 more locationsSponsor: Children's Oncology GroupSex: All·Age: Up to 21Code: NCT05304585·Phase 3·Recruiting·Listed Mar 2022Apply to this trial
Prospective Laboratory Study Biologic Specimens and Tumor Tissue of Patients With Cancerfor Ovarian Cancer1 location in AlbuquerqueSponsor: New Mexico Cancer Research AllianceSex: Female·Age: 18+Code: NCT03943316·Recruiting·Listed May 2019Apply to this trial
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancerfor Rectal CancerSites in Albuquerque +102 more locationsSponsor: Canadian Cancer Trials GroupSex: All·Age: 18+Code: NCT06205485·Phase 3·Recruiting·Listed Jan 2024Apply to this trial
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)for Stage I Breast CancerSites in Albuquerque +706 more locationsSponsor: NRG OncologySex: All·Age: 50 - 70Code: NCT04852887·Phase 3·Recruiting·Listed Apr 2021Apply to this trial
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancerfor Recurrent Endometrial CarcinomaSites in Albuquerque +10 more locationsSponsor: National Cancer Institute (NCI)Sex: Female·Age: 18+Code: NCT05950464·Phase 1·Recruiting·Listed Jul 2023Apply to this trial
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)for Recurrent Lung Non-Small Cell CarcinomaDrug: CemiplimabSites in Albuquerque +380 more locationsSponsor: SWOG Cancer Research NetworkSex: All·Age: 18+Code: NCT06616584·Phase 2, Phase 3·Recruiting·Listed Sep 2024Apply to this trial
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancerfor Anatomic Stage IV Breast Cancer AJCC v8Sites in Albuquerque, Rio Rancho +584 more locationsSponsor: SWOG Cancer Research NetworkSex: All·Age: 18+Code: NCT03723928·Recruiting·Listed Oct 2018Apply to this trial
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinicsfor Breast CarcinomaSites in Albuquerque, Rio Rancho +462 more locationsSponsor: Wake Forest University Health SciencesSex: All·Age: 18+Code: NCT06418204·Recruiting·Listed May 2024Apply to this trial
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathyfor Malignant Solid NeoplasmSites in Albuquerque +32 more locationsSponsor: SWOG Cancer Research NetworkSex: All·Age: 18+Code: NCT05642611·Phase 3·Recruiting·Listed Dec 2022Apply to this trial
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumorsfor Metastatic Malignant Neoplasm in the LiverSites in Albuquerque +379 more locationsSponsor: SWOG Cancer Research NetworkSex: All·Age: 18+Code: NCT05040360·Phase 2·Recruiting·Listed Sep 2021Apply to this trial
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphomafor Diffuse Large B-Cell LymphomaSites in Albuquerque +82 more locationsSponsor: SWOG Cancer Research NetworkSex: All·Age: 18+Code: NCT05633615·Phase 2·Recruiting·Listed Dec 2022Apply to this trial
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicityfor CardiotoxicitySites in Albuquerque +143 more locationsSponsor: SWOG Cancer Research NetworkSex: All·Age: 18+Code: NCT03418961·Phase 3·Recruiting·Listed Feb 2018Apply to this trial
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Studyfor Hematopoietic and Lymphatic System NeoplasmSites in Albuquerque +75 more locationsSponsor: Children's Oncology GroupSex: All·Age: 15 - 20Code: NCT06410209·Phase 2·Recruiting·Listed May 2024Apply to this trial
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trialfor Metastatic Clear Cell Renal Cell CarcinomaSites in Albuquerque +339 more locationsSponsor: SWOG Cancer Research NetworkSex: All·Age: 18+Code: NCT04510597·Phase 3·Recruiting·Listed Aug 2020Apply to this trial
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatmentfor Hodgkin Lymphoma in RemissionSites in Albuquerque +55 more locationsSponsor: Children's Oncology GroupSex: All·Age: All agesCode: NCT01790152·Recruiting·Listed Feb 2013Apply to this trial
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcomafor Endometrial CarcinomaSites in Albuquerque +326 more locationsSponsor: National Cancer Institute (NCI)Sex: Female·Age: 18+Code: NCT05256225·Phase 3·Recruiting·Listed Feb 2022Apply to this trial